Fig. 6From: NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinomaa WB assay and quantitative analysis of the expression of GPX4 and SLC7A11 in vitro studies. b WB assay and quantitative analysis of the expression of P-gp in SMMC-7721 cells treated by PBS, SOR, MCPF, or MSCPF (660 nm irradiation at 500 mW cm−2 and 808 nm irradiation at 1.5 W cm−2). c Concentration assay of sorafenib in cells after SOR, MCPF and MSCPF treatment using Uv-vis spectrophotometryBack to article page